Literature DB >> 15209519

Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41.

Stephen A Gallo1, G Marius Clore, John M Louis, Carole A Bewley, Robert Blumenthal.   

Abstract

Peptides derived from the N- (N-HR) and C- (C-HR) terminal heptad repeat regions adjacent to the fusion peptide and transmembrane domains, respectively, of human immunodeficiency virus (HIV)-1 gp41 inhibit HIV-1 viral envelope glycoproteins (Env)-mediated cell fusion specifically. The mechanism of HIV-1 Env-mediated cell fusion and its inhibition by agents that target the N- and C-HR regions was investigated. Priming experiments with Env-expressing cells indicate that the N-HR region but not the C-HR region is exposed by treatment with sCD4 at 31 degrees C, whereas both the N- and C-HR regions are exposed at 37 degrees C.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15209519     DOI: 10.1021/bi049957v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation.

Authors:  Antony S Dimitrov; John M Louis; Carole A Bewley; G Marius Clore; Robert Blumenthal
Journal:  Biochemistry       Date:  2005-09-20       Impact factor: 3.162

2.  Restraining the conformation of HIV-1 gp120 by removing a flexible loop.

Authors:  Sophia Rits-Volloch; Gary Frey; Stephen C Harrison; Bing Chen
Journal:  EMBO J       Date:  2006-09-28       Impact factor: 11.598

3.  pH regulation in early endosomes and interferon-inducible transmembrane proteins control avian retrovirus fusion.

Authors:  Tanay M Desai; Mariana Marin; Caleb Mason; Gregory B Melikyan
Journal:  J Biol Chem       Date:  2017-03-24       Impact factor: 5.157

4.  Synergistic inhibition of HIV-1 envelope-mediated membrane fusion by inhibitors targeting the N and C-terminal heptad repeats of gp41.

Authors:  Elena Gustchina; John M Louis; Carole A Bewley; G Marius Clore
Journal:  J Mol Biol       Date:  2006-09-12       Impact factor: 5.469

5.  Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.

Authors:  Shan Su; Yun Zhu; Sheng Ye; Qianqian Qi; Shuai Xia; Zhenxuan Ma; Fei Yu; Qian Wang; Rongguang Zhang; Shibo Jiang; Lu Lu
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

6.  Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events.

Authors:  Hsu-Tso Ho; Li Fan; Beata Nowicka-Sans; Brian McAuliffe; Chang-Ben Li; Gregory Yamanaka; Nannan Zhou; Hua Fang; Ira Dicker; Richard Dalterio; Yi-Fei Gong; Tao Wang; Zhiwei Yin; Yasutsugu Ueda; John Matiskella; John Kadow; Paul Clapham; James Robinson; Richard Colonno; Pin-Fang Lin
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Solution structure of the monovalent lectin microvirin in complex with Man(alpha)(1-2)Man provides a basis for anti-HIV activity with low toxicity.

Authors:  Syed Shahzad-ul-Hussan; Elena Gustchina; Rodolfo Ghirlando; G Marius Clore; Carole A Bewley
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

8.  Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion.

Authors:  Gregory B Melikyan; Marc Egelhofer; Dorothee von Laer
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

9.  HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: implications for therapy and vaccine development.

Authors:  Amy Jacobs; Himanshu Garg; Mathias Viard; Yossef Raviv; Anu Puri; Robert Blumenthal
Journal:  Vaccine       Date:  2008-01-10       Impact factor: 3.641

10.  Stability of a receptor-binding active human immunodeficiency virus type 1 recombinant gp140 trimer conferred by intermonomer disulfide bonding of the V3 loop: differential effects of protein disulfide isomerase on CD4 and coreceptor binding.

Authors:  J Billington; T P Hickling; G H Munro; C Halai; R Chung; G G Dodson; R S Daniels
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.